Synexus Clinical Research US, Inc
Saint Louis, Missouri, United States
Doctor in Creve Coeur, Missouri
675 Old Ballas Rd #103, Creve Coeur, MO 63141
About Synexus Clinical Research US, Inc
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Synexus Clinical Research US, Inc
During the past decade, Synexus Clinical Research US, Inc conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 3 clinical trials were completed, i.e. on
average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)
2014-08-18
2026-10-10
Active, not recruiting
450
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
2014-08-18
Recruiting
8,300
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
2014-08-18
2036-05-01
Recruiting
168
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
2015-07-13
2023-10-02
Active, not recruiting
300
A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma
2015-09-10
2033-06-30
Recruiting
600
Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy
2015-04-29
2031-03-29
Active, not recruiting
415
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
2015-08-12
2025-12-31
Active, not recruiting
6,452
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Synexus Clinical Research US, Inc"
#1 collaborator was "Brigham and Women's Hospital" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Synexus Clinical Research US, Inc
According to Clinical.Site data, the most researched conditions in "Synexus Clinical Research US, Inc" are
"Diabetes Mellitus" (2 trials), "Gastroparesis" (2 trials), "Respiratory Syncytial Viruses" (2 trials), "Chikungunya Virus" (1 trials) and "Dyslipidemia" (1 trials). Many other conditions were trialed in "Synexus Clinical Research US, Inc" in a lesser frequency.
Clinical Trials Intervention Types at Synexus Clinical Research US, Inc
Most popular intervention types in "Synexus Clinical Research US, Inc" are "Biological" (5 trials), "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (8 trials), "Relamorelin" (2 trials), "Ad26.COV2.S" (1 trials), "Ad26.RSV.preF-based vaccine" (1 trials) and "Adenovirus serotype 26 (Ad26)-based respiratory syncytial virus (RSV). preF" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Synexus Clinical Research US, Inc
The vast majority of trials in "Synexus Clinical Research US, Inc" are
8 trials for "All" genders.
Clinical Trials Status at Synexus Clinical Research US, Inc
Currently, there are NaN active trials in "Synexus Clinical Research US, Inc".
undefined are not yet recruiting,
1 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Synexus Clinical Research US, Inc,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Synexus Clinical Research US, Inc, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 7 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".